Atrial Fibrillation in Advanced Chronic Kidney Disease: To Anticoagulate or Not, and With What? UCSF Department of Medicine 2026-09-21 | Atrial Fibrillation in Advanced Chronic Kidney Disease: To Anticoagulate or Not, and With What?
How a Needs-First Framework and AI Can Transform Patient Care UCSF Department of Medicine 2025-09-26 | Pairing a needs-first framework with the power of artificial intelligence can open new frontiers in clinical care, research, and program development. This Grand Rounds will explore how AI can accelerate progress – sparking ideas, uncovering unmet needs, and streamlining implementation – to transform patient care. Speakers:Liviu Klein, MD, MS, is a professor of medicine in the Division of Cardiology at UCSF Health and director of the UCSF Advanced Heart Failure Comprehensive Care Center. His work aims to develop new diagnostic sensors, therapeutic devices, and artificial intelligence tools for patients with cardiovascular disease. Shweta Motiwala, MD, MPH, is an associate professor of medicine in the Division of Cardiology at UCSF Health and director of Heart Failure Disease Management. Her work focuses on improving outcomes in heart failure through remote monitoring platforms, optimized therapies, biomarkers, novel devices, and expanded access to care. Jin Ge, MD, MBA, is an assistant professor of medicine and director of Clinical AI in the Division of Gastroenterology at UCSF Health and the Division of Clinical Informatics and Digital Transformation. His research focuses on using clinical informatics, data science, and artificial intelligence to improve care for patients with liver disease. Rush Bartlett, PhD, MBA, is co-founder and chief executive officer of Sluice AI. A 5X startup founder, he has trained and advised top healthcare companies, served in leadership roles at Stanford Biodesign and UCSF, and previously led Vynca Health, which has supported over 1 million patients.Program:Michelle Mourad: Introduction3:30-19:25 — Liviu Klein, MD, MS19:26-26:21 — Jin Ge, MD, MBA26:22-34:59 — Shweta Motiwala, MD, MPH35:00-47:43 — Rush Bartlett, PhD, MBA47:44-54:39 — Q&ASee previous Medical Grand Rounds: September 16: Updates in the Diagnosis and Management of Delirium • youtu.be/a0pVKL3bLs0September 9: Hepatitis C: Are We There Yet? Updates and the Road Ahead • youtu.be/XrJdMxTmQOwJune 17: Serious Illness Accompaniment: End of Life Option Act Care at UCSF • youtu.be/TsEf4NWCgG8June 10: Viral Summer: Navigating the Evolving Landscape of COVID-19, H5N1 Influenza, and Measles • youtu.be/gFQ1dh5vBrY
Updates in the Diagnosis and Management of Delirium UCSF Department of Medicine 2025-09-19 | Delirium is one of the most common and debilitating hospital-acquired syndromes, but there is hope: new evidence is giving us better tools to detect and manage it. This Grand Rounds will highlight updates in the field, such as validated screening tools and strategies for prevention and treatment.Speakers:Sara LaHue, MD, is an assistant professor of neurology at UCSF Health and a Beeson and Butler-Williams Scholar whose research examines delirium, cognitive impairment, and aging biology among hospitalized older adults.Erik Levinsohn, MD, is an assistant professor of psychiatry at UCSF Health. His clinical work focuses on inpatient psychiatric consultation, with particular interests in delirium, capacity assessment, critical care psychiatry, and medical ethics.Program:Michelle Mourad: Introduction2:44-18:59 — Sara LaHue, MD19:00-47:24 — Erik Levinsohn, MD47:25-100:58 — Q&ASee previous Medical Grand Rounds: September 9: Hepatitis C: Are We There Yet? Updates and the Road Ahead • youtu.be/XrJdMxTmQOwJune 17: Serious Illness Accompaniment: End of Life Option Act Care at UCSF • youtu.be/TsEf4NWCgG8June 10: Viral Summer: Navigating the Evolving Landscape of COVID-19, H5N1 Influenza, and Measles • youtu.be/gFQ1dh5vBrYJune 3: Non-Insulin Medications for Diabetes: Choosing Wisely in the Face of the Many New Options • youtu.be/Rw8YDVO4mVc
Hepatitis C: Are We There Yet? Updates and the Road Ahead UCSF Department of Medicine 2025-09-15 | Although curative therapies have transformed hepatitis C care, gaps in diagnosis, access, and prevention still stand in the way of its elimination. In this Grand Rounds, Jennifer Price will highlight advances in diagnosis and treatment options and review the persistent challenges and priorities shaping the future of hepatitis C care.Speaker:Jennifer Price, MD, PhD, is a professor of medicine in the Division of Gastroenterology and Hepatology at UCSF Health and the director of the UCSF Viral Hepatitis Center. Her clinical work focuses on improving access to care among people living with HCV.Program: Allison Bond: Introduction1:04-46:10 — Jennifer Price, MD, PhD46:10-56:56 — Q&ASee previous Medical Grand Rounds: June 17: Serious Illness Accompaniment: End of Life Option Act Care at UCSF • youtu.be/TsEf4NWCgG8June 10: Viral Summer: Navigating the Evolving Landscape of COVID-19, H5N1 Influenza, and Measles • youtu.be/gFQ1dh5vBrYJune 3: Non-Insulin Medications for Diabetes: Choosing Wisely in the Face of the Many New Options • youtu.be/Rw8YDVO4mVcMay 27: Best Practices for Mentorship and People Development at UCSF and Beyond in 2025 • youtu.be/QP-rMFaBXLg
Serious Illness Accompaniment: End of Life Option Act Care at UCSF UCSF Department of Medicine 2025-06-18 | Join us for a discussion of end-of-life care under California’s End of Life Option Act (EOLOA), which permits adults with a life expectancy of less than six months to request medication to end their lives. This Grand Rounds will explore the history of EOLOA policy, UCSF’s approach to supporting patients pursuing this path, and key clinical lessons learned through implementation. Speakers will highlight special circumstances that can complicate care and share emerging insights on how UCSF is navigating the complexities and opportunities in this space. Speakers:Brieze Bell, MD, is an assistant professor in the Divisions of Palliative Medicine and Hospital Medicine at UCSF Health and the medical director of the UCSF End of Life Option Act. She completed her Internal Medicine residency at Massachusetts General Hospital and fellowships in Palliative Medicine and Integrative Medicine at UCSF. Eve Cohen, RN, BSN, is a palliative care nurse and the nurse program coordinator for the UCSF Palliative Care Clinic, a multidisciplinary team that focuses on improving quality of life for patients with serious illnesses. Teddy Scheel, LCSW, MPH, is a social work supervisor at the UCSF Helen Diller Family Comprehensive Cancer Center, where he co-manages the Oncology Social Work Department. In addition, he serves as a palliative care social worker in the Division of Palliative Medicine at UCSF Health. He previously completed his internship at the Alvin J. Siteman Cancer Center.Program: Michelle Mourad: Introductions 7:25-20:50 — Brieze Bell, MD20:50-29:40 — Teddy Scheel, LCSW, MPH29:40-40:00 — Eve Cohen, RN, BSN40:00-58:46 — Q&ASee previous Medical Grand Rounds: June 10: Viral Summer: Navigating the Evolving Landscape of COVID-19, H5N1 Influenza, and Measles • youtu.be/gFQ1dh5vBrYJune 3: Non-Insulin Medications for Diabetes: Choosing Wisely in the Face of the Many New Options • youtu.be/Rw8YDVO4mVcMay 27: Best Practices for Mentorship and People Development at UCSF and Beyond in 2025 • youtu.be/QP-rMFaBXLgMay 20: Hollander Rounds: A Clinical Problem-Solving Case • youtu.be/966ov_MGCEw
Viral Summer: Navigating the Evolving Landscape of COVID-19, H5N1 Influenza, and Measles UCSF Department of Medicine 2025-06-13 | Join Peter Chin-Hong for a timely discussion on the evolving landscape of viral infections, focusing on COVID-19, H5N1 influenza, and measles. This Grand Rounds will cover the latest epidemiological trends, review best practices in clinical management, and highlight prevention strategies. Attendees will leave better equipped to counsel patients, tailor treatment plans, and navigate the shifting viral threats anticipated this summer.Speaker:Peter Chin-Hong, MD, is a professor of medicine in the Division of Infectious Diseases at UCSF Health and serves as the associate dean for UCSF Regional Campuses. He was the founding director of the Immunocompromised Host Infectious Diseases Fellowship Program at UCSF and has received the AME Endowed Chair for Innovation in Teaching, the UCSF Henry J. Kaiser Award for Excellence in Teaching, and the UCSF Bridges Curriculum Foundations Teaching Award for the Class of 2020. Program: Michelle Mourad: Introduction 2:15-51:15 — Peter Chin-Hong, MD51:15-1:00:06 — Q&ASee previous Medical Grand Rounds: June 3: Non-Insulin Medications for Diabetes: Choosing Wisely in the Face of the Many New Options • youtu.be/Rw8YDVO4mVcMay 27: Best Practices for Mentorship and People Development at UCSF and Beyond in 2025 • youtu.be/QP-rMFaBXLgMay 20: Hollander Rounds: A Clinical Problem-Solving Case • youtu.be/966ov_MGCEwMay 15: Leadership 201: Lessons Learned from Leading Through Pandemics and Political Partisanship • youtu.be/D21IAH3Jb5g
Non-Insulin Medications for Diabetes: Choosing Wisely in the Face of the Many New Options UCSF Department of Medicine 2025-06-04 | Treatment options for diabetes medications are constantly evolving, and it's easy to get lost in the alphabet soup of non-insulin diabetes medications. Join Sarah Kim for a practical review of non-insulin medications for diabetes, with a focus on GLP-1 receptor agonists and SGLT-2 inhibitors. This Grand Rounds will explore how to identify the right (and wrong) oral regimens for patients with diabetes based on specific clinical scenarios. Attendees will leave with greater confidence in personalizing a diabetes treatment plan beyond insulin, an essential skill in both inpatient and outpatient care.Speaker:Sarah Kim, MD, is a professor of medicine in the Division of Endocrinology and Metabolism at ZSFG and the director of the UCSF Diabetes Teaching Center. Her clinical work focuses on adult diabetes and adult and pediatric obesity. She also provides care for the San Francisco's safety net population, which includes many of the city's 73,000 uninsured residents.Program: Bob Wachter: Introduction 1:12-43:26 — Sarah Kim, MD43:26-58:38 — Q&ASee previous Medical Grand Rounds: May 27: Best Practices for Mentorship and People Development at UCSF and Beyond in 2025 • youtu.be/QP-rMFaBXLgMay 20: Hollander Rounds: A Clinical Problem-Solving Case • youtu.be/966ov_MGCEwMay 15: Leadership 201: Lessons Learned from Leading Through Pandemics and Political Partisanship • youtu.be/D21IAH3Jb5gMay 6: Medical Care for Low-Income Populations • youtu.be/lS9CNUcXnEk
Best Practices for Mentorship and People Development at UCSF and Beyond in 2025 UCSF Department of Medicine 2025-06-04 | Effective mentorship is intentional. In this Grand Rounds, we will explore evidence-based practices for fostering professional growth through structured guidance. Drawing on research and real-world programs from UCSF and beyond, we will highlight proven strategies for designing impactful development initiatives. Whether you are a mentor, a mentee, or shaping career development programs, you will leave with practical tools and resources to help cultivate a thriving culture of mentorship and sustained professional success.Speaker:Lekshmi Santhosh, MD, MAEd, is an associate professor in the Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine at UCSF Health and the inaugural associate chair for people development and mentorship in the UCSF Department of Medicine. She is the chair-elect for the American Thoracic Society Section on Medical Education, the associate program director for the UCSF Internal Medicine Residency, and holds the UCSF Gold-Headed Cane Endowed Education Chair in Internal Medicine.Program: Bob Wachter: Introduction 2:40-49:50 — Lekshmi Santhosh, MD, MAEd49:50-1:00:06 — Q&ASee previous Medical Grand Rounds: May 20: Hollander Rounds: A Clinical Problem-Solving Case • youtu.be/966ov_MGCEwMay 15: Leadership 201: Lessons Learned from Leading Through Pandemics and Political Partisanship • youtu.be/D21IAH3Jb5gMay 6: Medical Care for Low-Income Populations • youtu.be/lS9CNUcXnEkApril 29: Interstitial Lung Disease Associated with Connective Tissue Diseases • youtu.be/V4RI_81ffKg
Hollander Rounds: A Clinical Problem-Solving Case UCSF Department of Medicine 2025-05-22 | In our Hollander Clinical Problem Solving Rounds, we observe how master clinicians reason through challenging cases, joining them on the diagnostic journey and learning from how they navigate each twist and turn as the story unfolds in real time. For this Hollander Rounds, our discussant will be Rachel Bystritsky.Speaker:Rachel Bystritsky, MD, is an associate professor in the Division of Infectious Diseases at UCSF Health and serves as medical director of the UCSF Outpatient Parenteral Antimicrobial Therapy (OPAT) Program. She provides care to outpatients in the UCSF infectious disease clinics and serves on the inpatient consult services at UCSF Medical Center.Program: Bob Wachter: Introduction 2:30-53:50 — Rachel Bystritsky, MD53:50-57:43 — Q&ASee previous Medical Grand Rounds: May 15: Leadership 201: Lessons Learned from Leading Through Pandemics and Political Partisanship • youtu.be/D21IAH3Jb5gMay 6: Medical Care for Low-Income Populations • youtu.be/lS9CNUcXnEkApril 29: Interstitial Lung Disease Associated with Connective Tissue Diseases • youtu.be/V4RI_81ffKgApril 22: Redefining Mild Aortic Stenosis • youtu.be/1dFCwnxk5ks
Leadership 201: Lessons Learned from Leading Through Pandemics and Political Partisanship UCSF Department of Medicine 2025-05-16 | For the 27th annual Holly Smith Visiting Professorship Grand Rounds, we welcome Carlos del Rio, the chair of the Scientific Advisory Board for the President's Emergency Plan for AIDS Relief (PEPFAR) and the chair of the Department of Medicine at Emory University School of Medicine. Del Rio will explore successful leadership approaches to high-stakes crises, including global pandemics, online disinformation, and today’s increasingly partisan political divide.The annual Holly Smith Visiting Professorship is the UCSF Department of Medicine’s most prestigious yearly lectureship. It is named for Lloyd Hollingsworth “Holly” Smith Jr., MD, a visionary physician-scientist whose uncompromising commitment to excellence helped transform UCSF into the world-renowned institution it is today. Smith served as chair of the UCSF Department of Medicine for 21 years, and associate dean for the UCSF School of Medicine for another decade.Speaker:Carlos del Rio, MD, is the chair of the Department of Medicine at Emory University School of Medicine and a professor of global health and epidemiology at the Rollins School of Public Health. He also serves as the chair of the Scientific Advisory Board for the United States President’s Emergency Plan for AIDS Relief (PEPFAR) and is the immediate past president of the Infectious Diseases Society of America. A global leader in HIV research and policy, del Rio's research focuses on access to care, patient engagement, adherence to antiretroviral therapy, and the prevention of HIV infection. He has received the American Public Health Association (APHA) Award for Excellence in Public Health. Program: Bob Wachter: Introduction 3:10-51:10 — Carlos del Rio, MD51:10-1:01:27 — Q&ASee previous Medical Grand Rounds: May 6: Medical Care for Low-Income Populations • youtu.be/lS9CNUcXnEkApril 29: Interstitial Lung Disease Associated with Connective Tissue Diseases • youtu.be/V4RI_81ffKgApril 22: Redefining Mild Aortic Stenosis • youtu.be/1dFCwnxk5ksApril 15: Human Reasoning, AI Models, and the Race Toward a Strange New Type of Collaboration • youtu.be/bRVv-qxDpKs
UCSF Rheumatology Fellowship Program UCSF Department of Medicine 2025-05-16 | The UCSF Rheumatology Fellowship Program is committed to advancing health worldwide by training outstanding rheumatologists who are equipped to lead in academic and clinical rheumatology. Our comprehensive fellowship program develops skilled practitioners, pioneering researchers, and dedicated educators. These professionals are prepared to enhance patient outcomes through innovative care and research, addressing rheumatologic diseases at local, national, and international levels. Upholding UCSF’s tradition of excellence in education, patient care, research, and public service, we strive to transform scientific discoveries into enhanced health outcomes for all, particularly the world’s most vulnerable populations.
Medical Care for Low-Income Populations UCSF Department of Medicine 2025-05-07 | Medicaid faces unprecedented political and fiscal pressures, with ripple effects that particularly threaten vulnerable patients. Mitchell Katz, the president and CEO of NYC Health + Hospitals, will review the complexities unique to providing medical care to low-income populations. Katz will also provide an overview of how the United States funds care for low-income patients through a patchwork of federal, state, and local programs — and what happens when funding contracts. Understanding these dynamics is essential for clinicians, policymakers, and anyone invested in equitable care delivery.Speaker:Mitchell Katz, MD, is the president and CEO of NYC Health + Hospitals, the largest municipal healthcare system in the United States. Since his appointment in 2018, the New York City system has significantly expanded access to medical care, including through the creation of NYC Care, a universal access program for uninsured New Yorkers. He previously served as the director of the L.A. County Department of Health Services and as the director and health officer of the San Francisco Department of Public Health, where he launched Healthy San Francisco. Katz is a graduate of our UCSF Internal Medicine residency program.Program: Bob Wachter: Introduction 2:01-41:30 — Mitchell Katz, MD41:30-1:00:41 — Q&ASee previous Medical Grand Rounds: April 29: Interstitial Lung Disease Associated with Connective Tissue Diseases • youtu.be/V4RI_81ffKgApril 22: Redefining Mild Aortic Stenosis • youtu.be/1dFCwnxk5ksApril 15: Human Reasoning, AI Models, and the Race Toward a Strange New Type of Collaboration • youtu.be/bRVv-qxDpKsApril 1: The Path From NIH Funding of Basic Science to New Therapeutics • youtu.be/EaGUfmdeWQk
Interstitial Lung Disease Associated with Connective Tissue Diseases UCSF Department of Medicine 2025-05-02 | From nuanced patient care to emerging molecular pathways, this Medical Grand Rounds will demystify connective tissue disease-associated interstitial lung disease (CTD-ILD) and explore how cutting-edge genetics and clinical insights are converging to shape diagnostics and therapeutics. Through a discussion of early recognition, risk stratification, and personalized treatment strategies, attendees will learn practical tools to inform clinical practice.Speakers:Andrew Gross, MD, is professor and clinical chief of Rheumatology at UCSF Health and co-director of the UCSF Scleroderma Center. Gross works closely with UCSF physicians, immunology researchers, and specialists in the UCSF Interstitial Lung Disease Program to provide comprehensive care to patients with complex conditions.Rupal Shah, MD, MS, is an associate professor and the medical director of adult patient experience in the Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine at UCSF Health. She sees patients on the Lung Transplant and Interstitial Lung Disease services. Shah received the UCSF Exceptional Physician Award in 2022.Anthony Shum, MD, is a professor in the Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine at UCSF Health. His lab recently helped discover the genetic basis of COPA syndrome, an inherited autoimmune disorder that can lead to severe lung and joint disease. Shum also identified a novel lung-specific antigen that is targeted in patients with autoimmune lung disease and demonstrated that autoantibodies to this antigen could be used as a biomarker to detect patients with lung autoimmunity.Program: Allison Bond: Introduction 1:45-8:05 — Rupal Shah, MD, MS8:05-34:30 — Andrew Gross, MD34:30-40:15 — Rupal Shah, MD, MS40:15-56:12 — Anthony Shum, MD56:12-1:01:08 — Q&ASee previous Medical Grand Rounds: April 22: Redefining Mild Aortic Stenosis • youtu.be/1dFCwnxk5ksApril 15: Human Reasoning, AI Models, and the Race Toward a Strange New Type of Collaboration • youtu.be/bRVv-qxDpKsApril 1: The Path From NIH Funding of Basic Science to New Therapeutics • youtu.be/EaGUfmdeWQkMarch 25: More Money, Fewer Problems? Examining Guaranteed Income and Housing Stability • youtu.be/pwwG1y4_gU8
Redefining Mild Aortic Stenosis UCSF Department of Medicine 2025-04-25 | Mild aortic stenosis has long been viewed as clinically silent, but emerging evidence suggests it may be quietly dangerous. While no medical therapies have been proven to slow its progression, patients with so-called mild disease face significantly higher risks of heart failure, atrial fibrillation, and death. This Grand Rounds will examine whether current definitions and management strategies should be re-evaluated in light of our emerging understanding of the risks associated with early-stage aortic stenosis.Speaker:James Pirruccello, MD, is an assistant professor in the Division of Cardiology at UCSF Health and an associate editor at the Journals of the American College of Cardiology. His research focuses on cardiovascular and aortic disease, using machine learning to enable large-scale phenotyping in humans. James’ lab analyzes the genetic basis of these cardiovascular phenotypes to gain insight into the mechanisms of disease.Program Bob Wachter: Introduction 1:40-40:10 — James Pirruccello, MD40:10-55:57 — Q&ASee previous Medical Grand Rounds: April 15: Human Reasoning, AI Models, and the Race Toward a Strange New Type of Collaboration • youtu.be/bRVv-qxDpKsApril 1: The Path From NIH Funding of Basic Science to New Therapeutics • youtu.be/EaGUfmdeWQkMarch 25: More Money, Fewer Problems? Examining Guaranteed Income and Housing Stability • youtu.be/pwwG1y4_gU8March 11: Air Pollution, Asthma, Allergy, and the Exposome • youtu.be/RK3T0UAGE0k
Human Reasoning, AI Models, and the Race Toward a Strange New Type of Collaboration UCSF Department of Medicine 2025-04-16 | For this special Grand Rounds, we are excited to welcome Adam Rodman, an expert in clinical reasoning and decision-making, to UCSF to explore the fascinating intersection of AI and human reasoning. Attendees will gain a deeper understanding of how human-computer interactions and collaboration might complement, rather than replace, human judgment, and how AI and reasoning models in medicine are poised to transform clinical decision-making.We established this annual Master Clinician Visiting Professorship, through a generous gift from a donor, to recognize the contributions of our many Master Clinicians in the DOM. Every year our visiting professor gives the Gurpreet Dhaliwal Lecture in Medicine, which is named after our legendary clinician-educator and Master Clinician Gurpreet Dhaliwal.Speaker:Adam Rodman, MD, MPH, is an assistant professor of medicine at Beth Israel Deaconess Medical Center and Harvard Medical School. He is an associate editor at The New England Journal of Medicine AI, the host of the American College of Physicians' podcast Bedside Rounds, and the author of the book Short Cuts: Medicine.Program Bob Wachter: Introduction 2:50-51:10 — Adam Rodman, MD, MPH51:10-1:02:20 — Q&ASee previous Medical Grand Rounds: April 1: The Path From NIH Funding of Basic Science to New Therapeutics • youtu.be/EaGUfmdeWQkMarch 25: More Money, Fewer Problems? Examining Guaranteed Income and Housing Stability • youtu.be/pwwG1y4_gU8March 11: Air Pollution, Asthma, Allergy, and the Exposome • youtu.be/RK3T0UAGE0kFebruary 25: Updates in Large Vessel Vasculitis • youtu.be/gQX8Ewjr-kI
The Path From NIH Funding of Basic Science to New Therapeutics UCSF Department of Medicine 2025-04-07 | How does bench science get to the bedside? Now, more than ever, understanding how NIH-funded basic science research leads to groundbreaking medical treatments is crucial.Richard Lifton, an internationally renowned genetics researcher and president of Rockefeller University, will discuss the translation of fundamental discoveries into therapeutic innovations, bridging the gap between laboratory research and clinical applications. Attendees will gain insights into the funding process, the challenges of therapeutic development, and the impact of scientific advancements on public health.Speaker:Richard Lifton, MD, PhD, is the president of The Rockefeller University, the former chair of Genetics at Yale University, and the founder of the Yale Center for Genome Analysis. He serves as a director at Roche and its subsidiary, Genentech. Lifton has also served on the Advisory Council to the NIH Director, co-chaired the National Academy of Sciences and Royal Society's International Commission on the Clinical Use of Germline Genome Editing, and co-chaired the White House and NIH's Precision Medicine Planning Group. He was awarded the Breakthrough Prize in Life Sciences and the Association of American Physicians' Kober Medal.Program Bob Wachter: Introduction 2:15-54:15 — Richard Lifton, MD, PhD54:15-59:28 — Q&ASee previous Medical Grand Rounds: March 25: More Money, Fewer Problems? Examining Guaranteed Income and Housing Stability • youtu.be/pwwG1y4_gU8March 11: Air Pollution, Asthma, Allergy, and the Exposome • youtu.be/RK3T0UAGE0kFebruary 25: Updates in Large Vessel Vasculitis • youtu.be/gQX8Ewjr-kIFebruary 18: The 27th Annual Reza Gandjei Lecture: Focusing on Health Care Equity • youtu.be/7Z7FM-Apd2s
More Money, Fewer Problems? Examining Guaranteed Income and Housing Stability UCSF Department of Medicine 2025-03-29 | Housing insecurity remains a major issue in the Bay Area, as it is in many parts of the country. Could providing a financial safety net help? In this Medical Grand Rounds, implementation science expert Oanh Nguyen will explore the current evidence and evaluate the relationship between guaranteed income and secure housing outcomes. Attendees will take a critical look at the methodologies of existing studies – providing an evidence-based lens to view this important national and local debate.Speaker:Oanh Nguyen, MD, MAS, is an associate professor and chief of the Division of Hospital Medicine at ZSFG. She is a deputy editor for the Journal of Hospital Medicine and the director of hospital care at the UCSF PRISE Center Program. Nguyen is a recipient of the Society of Hospital Medicine Outstanding Junior Investigator Award, the ZSFG Junior Investigator Award, and she was named a 2022 Chan Zuckerberg Biohub Investigator.Program Bob Wachter: Introduction 1:35-31:00 — Oanh Nguyen, MD, MAS31:00-50:17 — Q&ASee previous Medical Grand Rounds: March 11: Air Pollution, Asthma, Allergy, and the Exposome • youtu.be/RK3T0UAGE0kFebruary 25: Updates in Large Vessel Vasculitis • youtu.be/gQX8Ewjr-kIFebruary 18: The 27th Annual Reza Gandjei Lecture: Focusing on Health Care Equity • youtu.be/7Z7FM-Apd2sFebruary 11: The Case for Geriatricizing Subspecialty Care • youtu.be/AWM0FIFMkfw
32nd Annual Alice Hamilton Lecture: Air Pollution, Asthma, Allergy, and the Exposome UCSF Department of Medicine 2025-03-14 | Human health is inextricably linked to our environment and can vary depending on genetic factors, socioeconomic disparities, and cumulative exposure to various environmental risks throughout one's life, known as the exposome. In this year’s Annual Alice Hamilton Lecture, guest speaker and expert Isabella Annesi-Maesano will explore the complex relationship between respiratory health—particularly allergies and asthma—and an individual's exposure to pollution. We will also discuss how researchers are harnessing digital technology and analytics to create personalized strategies for preventing and alleviating asthma and allergies.About the Annual Alice Hamilton Lecture:Every year, our UCSF Division of Occupational, Environmental, and Climate Medicine (OECM) sponsors a lectureship in honor of Alice Hamilton, the founder of the modern discipline of occupational medicine in the U.S. View past lectures on the OECM website.Speaker:Isabella Annesi-Maesano, MD, PhD, DSc, is a professor of environmental epidemiology at Montpellier University and the director of research at L'Institut National de la Santé et de la Recherche Médicale (INSERM). She is also the deputy director of the Desbrest Institute of Epidemiology and Public Health in Montpellier. She received the 2021 European Academy of Allergy and Clinical Immunology (EAACI) Clemens von Pirquet Award for Clinical Research and the 2018 American Academy of Allergy, Asthma & Immunology (AAAAI) Phil and Barbara Liebmann Award. Program Allison Bond: Introduction 0:30-53:30 — Isabella Annesi-Maesano, MD, PhD, DSc53:30-59:30 — Q&ASee previous Medical Grand Rounds: February 25: Updates in Large Vessel Vasculitis • youtu.be/gQX8Ewjr-kIFebruary 18: The 27th Annual Reza Gandjei Lecture: Focusing on Health Care Equity • youtu.be/7Z7FM-Apd2sFebruary 11: The Case for Geriatricizing Subspecialty Care • youtu.be/AWM0FIFMkfwFebruary 4: Hollander Rounds: Clinical Problem Solving with Daniel Minter • youtu.be/z5hv-FpLpzM
Updates in Large Vessel Vasculitis UCSF Department of Medicine 2025-03-04 | Sharon Chung, MD, and Sarah Goglin, MDSession moderated by Allison BondPatients with vasculitis often present with a perplexing constellation of seemingly unrelated symptoms and signs. At today's Medical Grand Rounds, we'll explore cutting-edge clinical advances and scientific insights in the management of large vessel vasculitis. Our speakers, Sharon Chung and Sarah Goglin, two of UCSF's leading experts in these complex disorders, will discuss advanced imaging techniques for diagnosis and disease monitoring, strategies for optimizing glucocorticoid therapy, and evidence-based approaches to mitigating treatment-related complications.Speakers:Sharon Chung, MD, is a professor of medicine in the Division of Rheumatology at UCSF Health and the director of the UCSF Vasculitis Clinic. She also serves as the director of Clinical and Translational Medicine at the Immune Tolerance Network and the chair of the American College of Rheumatology Vasculitis Guidelines development committee.Sarah Goglin, MD, is an associate professor of medicine in the Division of Rheumatology at ZSFG, where she serves as the associate chief of education and the associate program director of its fellowship. She is also the associate director of the UCSF Vasculitis Clinic and a senior associate program director for the Internal Medicine Residency.Program Allison Bond: Introduction 2:00-26:50 — Sarah Goglin, MD26:50-49:30 — Sharon Chung, MD49:30-59:20 — Q&ASee previous Medical Grand Rounds: February 18: The 27th Annual Reza Gandjei Lecture: Focusing on Health Care Equity • youtu.be/7Z7FM-Apd2sFebruary 11: The Case for Geriatricizing Subspecialty Care • youtu.be/AWM0FIFMkfwFebruary 4: Hollander Rounds: Clinical Problem Solving with Daniel Minter • youtu.be/z5hv-FpLpzMJanuary 28: Hospital-Based Oncology for the Internist • youtu.be/cbrbVY3Fo7I
The 27th Annual Reza Gandjei Lecture: Focusing on Health Care Equity UCSF Department of Medicine 2025-02-21 | In the 27th annual Reza Gandjei lecture, health equity and policy thought leader Alicia Fernandez will discuss the social drivers of health screening, as well as strategies for reducing health disparities, including via systems-level and community-based approaches. This topic has never been more relevant given the current political landscape.This lecture series is in memory of Reza Gandjei, a UCSF medicine resident in the 1990s who passed away soon after training. Reza was a Marshall and Rhodes Scholar with a passion for healthcare ethics and policy.Speaker:Alicia Fernandez, MD, is a professor of medicine in the Division of General Internal Medicine at ZSFG and the associate dean of the Population Health and Health Equity data initiative at the UCSF School of Medicine. She is the founding director of the UCSF Latinx Center of Excellence and the director of the Latinx and Immigrant Health Research Program at the UCSF Center for Vulnerable Populations. She has been elected to the National Academy of Medicine and appointed to the U.S. Preventive Services Task Force.Program Bob Wachter: Introduction 3:15-36:40 — Alicia Fernandez, MD36:40-1:01:17 — Q&ASee previous Medical Grand Rounds: February 11: The Case for Geriatricizing Subspecialty Care • youtu.be/AWM0FIFMkfwFebruary 4: Hollander Rounds: Clinical Problem Solving with Daniel Minter • youtu.be/z5hv-FpLpzMJanuary 28: Hospital-Based Oncology for the Internist • youtu.be/cbrbVY3Fo7IJanuary 21: HIV in 2025: What’s New, What’s Next? • youtu.be/05fh2gRq6Ic
The Case for Geriatricizing Subspecialty Care UCSF Department of Medicine 2025-02-14 | An aging population with high rates of chronic diseases is reshaping the management of chronic illnesses. This Grand Rounds will delineate this shift while providing strategies for integrating geriatric principles into subspecialty care. G. Michael Harper and Leah Witt will highlight age-friendly UCSF partnerships and programs, and review actionable approaches to address the challenges posed by an aging society.Speakers:Michael G. Harper, MD, is a professor of medicine in the Division of Geriatrics at UCSF Health and a sustaining member of the UCSF Haile T. Debas Academy of Medical Educators. He is the chair of the board of directors of the American Geriatrics Society (AGS) and a member of the AGS executive committee. He currently sees patients at both the SFVAHCS and UCSF Health. At the SFVAHCS, he attends on the Mobile Acute Care for Elders (ACE) Service and supervises fellows in the Community Living Center and the SFVAHCS Geriatrics Clinic.Leah Witt, MD, is an associate professor in the Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine at UCSF Health, where she serves as the associate chief of pulmonary for ambulatory affairs. From 2019 to 2023, Witt was a HRSA Geriatric Academic Career Awardee for her work on interprofessional geriatrics education for chronic lung disease care. She has also served as a coach for the UCSF Pulmonary & Critical Care Medicine Fellowship. She is a member of the UCSF Academy of Medical Educators.Program Bob Wachter: Introduction 3:00-25:00 — Michael G. Harper, MD25:00-48:30 — Leah Witt, MD48:30-1:00:00 — Q&ASee previous Medical Grand Rounds: February 4: Hollander Rounds: Clinical Problem Solving with Daniel Minter • youtu.be/z5hv-FpLpzMJanuary 28: Hospital-Based Oncology for the Internist • youtu.be/cbrbVY3Fo7IJanuary 21: HIV in 2025: What’s New, What’s Next? • youtu.be/05fh2gRq6IcJanuary 7: The Cough Won't Stop: Updates in Bronchiectasis, from Airways to Bugs • youtu.be/e9XwIHaxxqo
Hollander Rounds: Clinical Problem Solving with Daniel Minter UCSF Department of Medicine 2025-02-07 | In our Hollander Clinical Problem Solving Rounds, we observe how master clinicians reason through challenging cases. While getting the diagnosis “right” is impressive, the learning comes from witnessing how experts navigate the zigs and zags of a diagnostic journey in a case that unfurls in real-time (as it does in life, of course). For this Hollander Rounds, our discussant will be Daniel Minter.Daniel Minter, MD, is an assistant professor in the Division of Infectious Diseases at UCSF Health. He has a special interest in caring for immunocompromised patients and patients with neurologic infections. Minter is a former UCSF resident and last year’s recipient of The Harry Hollander Award for Teaching in Clinical Reasoning. His primary academic interests involve medical education and clinical reasoning.Program Bob Wachter: Introduction 1:45-47:00 — Daniel Minter, MD 47:00-50:50 — Ella Cornell, MD50:50-1:00:30 — Q&ASee previous Medical Grand Rounds: January 28: Hospital-Based Oncology for the Internist • youtu.be/cbrbVY3Fo7IJanuary 21: HIV in 2025: What’s New, What’s Next? • youtu.be/05fh2gRq6IcJanuary 7: The Cough Won't Stop: Updates in Bronchiectasis, from Airways to Bugs • youtu.be/e9XwIHaxxqoDecember 10: Reactivation of Fetal Hemoglobin for Therapy: Status and Current Challenges • youtu.be/j5rmLMwVCaQ
Hospital-Based Oncology for the Internist UCSF Department of Medicine 2025-01-30 | Synopsis: Just as UCSF pioneered the Hospital Medicine specialty, we have also introduced an innovative care model in Hospital-Based Oncology (HBO). In this Medicine Grand Rounds, we will hear from Sam Brondfield on how the HBO team integrated oncology care into the hospital setting to provide more comprehensive, coordinated, multidisciplinary care. Attendees will learn practical best practices for caring for oncology patients in the inpatient setting, and explore how the lessons learned from HBO can be applied to improve clinical practice.Speakers:Sam Brondfield, MD, MAEdProgram Bob Wachter: Introduction 1:35-40:24 — Sam Brondfield, MD, MAEd 40:25-1:00:18 — Q&ASee previous Medical Grand Rounds: January 21: HIV in 2025: What’s New, What’s Next? • youtu.be/05fh2gRq6IcJanuary 7: The Cough Won't Stop: Updates in Bronchiectasis, from Airways to Bugs • youtu.be/e9XwIHaxxqoDecember 10: Reactivation of Fetal Hemoglobin for Therapy: Status and Current Challenges • youtu.be/j5rmLMwVCaQDecember 5: Preparing Clinicians for Diagnostic Artificial Intelligence: Tools, Teammates, and Teaching • youtu.be/JiWULSSLwnI
HIV in 2025: What’s New, What’s Next? UCSF Department of Medicine 2025-01-23 | Synopsis: Advances in HIV treatment have rapidly accelerated, with promising new trials and therapies emerging every year. In this Grand Rounds, one of our HIV experts, Annie Luetkemeyer, MD, will review current and emerging treatment and prevention tools and explore how these innovations are reshaping the landscape of HIV management. She will also discuss recent advances in the prevention of other sexually transmitted infections, another important strategy in HIV prevention. Speakers:Annie Luetkemeyer, MDProgram Bob Wachter: Introduction 1:07-57:21 — Annie Luetkemeyer, MD 57:22-1:01:08 — Q&ASee previous Medical Grand Rounds: January 7: The Cough Won't Stop: Updates in Bronchiectasis, from Airways to Bugs • youtu.be/e9XwIHaxxqoDecember 10: Reactivation of Fetal Hemoglobin for Therapy: Status and Current Challenges • youtu.be/j5rmLMwVCaQDecember 5: Preparing Clinicians for Diagnostic Artificial Intelligence: Tools, Teammates, and Teaching • youtu.be/JiWULSSLwnINovember 19: Multidisciplinary Approach to the Diagnosis and Treatment of Pulmonary Hypertension • youtu.be/hbTE9yQ5G1Y
The Cough Wont Stop: Updates in Bronchiectasis, from Airways to Bugs UCSF Department of Medicine 2025-01-09 | Synopsis: In this Medical Grand Rounds, Catherine DeVoe and Shoshana Zha will delve into the latest advancements in managing bronchiectasis, non-tuberculous mycobacterial (NTM) lung disease, and non-antimicrobial therapies. The speakers will provide practical strategies for distinguishing exacerbations from chronic symptoms, selecting the right antibiotic regimen for acute flare-ups, and exploring non-antimicrobial treatments aimed at halting disease progression. Attendees will sharpen their diagnostic skills in identifying pulmonary NTM lung disease and learn to apply patient-centered approaches that optimize treatment tolerance and ensure successful therapy completion.Speakers:Catherine DeVoe, MDShoshana Zha, MD, PhDProgram Bob Wachter: Introduction 3:28-32:54 — Shoshana Zha, MD, PhD 32:55-52:41 — Catherine DeVoe, MD52:42-1:00:25 — Q&ASee previous Medical Grand Rounds: December 10: Reactivation of Fetal Hemoglobin for Therapy: Status and Current Challenges • youtu.be/j5rmLMwVCaQDecember 5: Preparing Clinicians for Diagnostic Artificial Intelligence: Tools, Teammates, and Teaching • youtu.be/JiWULSSLwnINovember 19: Multidisciplinary Approach to the Diagnosis and Treatment of Pulmonary Hypertension • youtu.be/hbTE9yQ5G1YNovember 12: Advances in Rheumatoid Arthritis 2024: From Bench to Bedside • youtu.be/mdztWUW1lFw
Healing Together: Lessons Learned from Educational Leadership During Disruption UCSF Department of Medicine 2024-12-17 | The COVID-19 pandemic created widespread disruptions in clinical care and education. As the pandemic receded, educational leaders sought to rebuild institutional culture and regain the trust of trainees. In this Grand Rounds, we will explore the drivers of trainee mistrust and learn concrete strategies and educational leadership lessons borne from this unique era in our nation’s history.Speaker:Rebecca Berman, MDProgram Bob Wachter: Introduction 3:18-15:07— Rebecca Berman, MD See previous Medical Grand Rounds: December 10: Reactivation of Fetal Hemoglobin for Therapy: Status and Current Challenges • youtu.be/j5rmLMwVCaQDecember 5: Preparing Clinicians for Diagnostic Artificial Intelligence: Tools, Teammates, and Teaching • youtu.be/JiWULSSLwnINovember 19: Multidisciplinary Approach to the Diagnosis and Treatment of Pulmonary Hypertension • youtu.be/hbTE9yQ5G1YNovember 12: Advances in Rheumatoid Arthritis 2024: From Bench to Bedside • youtu.be/mdztWUW1lFw
Reactivation of Fetal Hemoglobin for Therapy: Status and Current Challenges UCSF Department of Medicine 2024-12-12 | Synopsis: Exciting new advances are underway for the treatment of patients with blood disorders such as sickle cell anemia and thalassemia. Understanding the basic science behind the mechanisms regulating fetal hemoglobin (HbF) is critical to exploring these novel therapeutics. Innovative research conducted at the Orkin lab has led to advancements in techniques for re-expressing HbF in adult red blood cells. In our annual Rudi Schmid Lecture, Stuart Orkin, MD, a Howard Hughes Medical Institute Investigator, will discuss the challenges and recent progress in using HbF reactivation as a therapeutic approach for hematologic diseases. Speaker:Stuart Orkin, MDProgram Lekshmi Santhosh: Introduction 2:41-52:22 — Stuart Orkin, MD 52:22-54:44 — Q&ASee previous Medical Grand Rounds: December 5: Preparing Clinicians for Diagnostic Artificial Intelligence: Tools, Teammates, and Teaching • youtu.be/JiWULSSLwnINovember 19: Multidisciplinary Approach to the Diagnosis and Treatment of Pulmonary Hypertension • youtu.be/hbTE9yQ5G1YNovember 12: Advances in Rheumatoid Arthritis 2024: From Bench to Bedside • youtu.be/mdztWUW1lFwNovember 5: Community-Engaged Climate Change Solutions • youtu.be/YhN4K7eA7Kk
Preparing Clinicians for Diagnostic Artificial Intelligence: Tools, Teammates, and Teaching UCSF Department of Medicine 2024-12-06 | As artificial intelligence (AI) transforms the healthcare landscape, who will train clinicians and trainees on the responsible and safe use of this technology? How will trainees’ clinical reasoning skills be impacted by AI – and will it help or hinder their learning? In this special Grand Rounds, Cornelius James, MD, from the University of Michigan, will explore the intersection of diagnostic AI and clinical practice, focusing on how AI tools can enhance diagnostic reasoning. James will highlight how AI is being integrated into diagnostic reasoning curricula to prepare the next generation of healthcare professionals to work effectively alongside AI systems.Speaker:Cornelius A. James, MD Assistant Professor Departments of Internal Medicine, Pediatrics, and Learning Health Sciences Program Bob Wachter: Introduction 3:10-2:05 — Cornelius A. James, MD 53:29-1:00:33 — Q&ASee previous Medical Grand Rounds: November 19: Multidisciplinary Approach to the Diagnosis and Treatment of Pulmonary Hypertension • youtu.be/hbTE9yQ5G1YNovember 12: Advances in Rheumatoid Arthritis 2024: From Bench to Bedside • youtu.be/mdztWUW1lFwNovember 5: Community-Engaged Climate Change Solutions • youtu.be/YhN4K7eA7KkOctober 29: Hospital Medicine: The Year in Review • youtu.be/j4V59fqdBDA
Multidisciplinary Approach to the Diagnosis and Treatment of Pulmonary Hypertension UCSF Department of Medicine 2024-11-25 | Pulmonary hypertension (PH) is a rapidly evolving condition that requires a multidisciplinary approach to ensure accurate diagnosis and effective treatment. This week's Grand Rounds will focus on the latest developments in PH management, beginning with the latest definitions, diagnostic strategies, and the full spectrum of treatment options. We'll learn from our medical, surgical, and interventional specialty colleagues who will highlight the multidisciplinary individualized plans needed for the care of these patients. Speakers:Marc Simon, MD, MSNicholas Kolaitis, MD, MASEmily Fedewa, NP, MSNMiles Conrad, MD, MPHHuie Lin, MD, PhDJasleen Kukreja, MD, MPHWilson Cui, MD, PhDProgram Lekshmi Santhosh: Introduction 3:10-12:42 — Marc Simon, MD, MS12:42-20:59 — Emily Fedewa, NP, MSN26:38-37:39— Miles Conrad, MD, MPH, Huie Lin, MD, PhD12:42-49:59 — Jasleen Kukreja, MD, MPH, Wilson Cui, MD, PhD49:59-59:31 — ReflectionsSee previous Medical Grand Rounds: November 12: Advances in Rheumatoid Arthritis 2024: From Bench to Bedside • youtu.be/mdztWUW1lFwNovember 5: Community-Engaged Climate Change Solutions • youtu.be/YhN4K7eA7KkOctober 29: Hospital Medicine: The Year in Review • youtu.be/j4V59fqdBDAOctober 22: Hollander Rounds: Clinical Problem Solving with Rabih Geha and Reza Manesh • youtu.be/lOX3B_PukT4
Patient Death in the Primary Care Setting UCSF Department of Medicine 2024-11-15 | 00:00 Introduction01:15 Documentation and notification04:05 Death certificate completion09:43 Honoring Patients and Supporting Loved Ones12:56 Support Resources for Clinicians
Advances in Rheumatoid Arthritis 2024: From Bench to Bedside UCSF Department of Medicine 2024-11-14 | The gut microbiome plays a fascinating role in the treatment of rheumatic diseases like rheumatoid arthritis (RA). In this Grand Rounds, our speakers will highlight the impact of the gut microbiome on therapeutic efficacy, and how gut bacteria metabolize drugs and influence the body's autoimmune processes. They will also discuss how insights gleaned from the gut microbiome and the pathogenesis of RA can be harnessed to find novel therapeutic targets that could revolutionize treatment for RA and other diseases.Speakers:Jonathan Graf, MDRenuka Nayak, MD, PhDProgram Michelle Mourad: Introduction 2:27-35:36 — Jonathan Graf, MD35:36-52:57 — Renuka Nayak, MD, PhD56:17-1:01:03 — ReflectionsSee previous Medical Grand Rounds: November 5: Community-Engaged Climate Change Solutions • youtu.be/YhN4K7eA7KkOctober 29: Hospital Medicine: The Year in Review • youtu.be/j4V59fqdBDAOctober 22: Hollander Rounds: Clinical Problem Solving with Rabih Geha and Reza Manesh • youtu.be/lOX3B_PukT4October 1: Prostate Cancer in 2024: Recent Updates and Treatment Advances • youtube.com/watch?v=47RJ7THtCVE
Community-Engaged Climate Change Solutions: Exposure Science and Intervention Research UCSF Department of Medicine 2024-11-07 | Extreme weather and changing patterns of infectious diseases are occurring due to climate change, to increasingly devastating effect. In this Grand Rounds, you will learn about the myriad impacts of climate change on health from two of our own UCSF climate change experts. We’ll also discuss strategies to collaborate with communities to mitigate these impacts.Speakers:Gina Solomon, MD, MPHMatthew Gribble, PhDProgram Bob Wachter: Introduction 2:27-27:09 — Gina Solomon, MD, MPH27:09-46:41 — Matthew Gribble, PhD46:41-1:01:07 — Q&ASee previous Medical Grand Rounds: October 29: Hospital Medicine: The Year in Review • youtu.be/j4V59fqdBDAOctober 22: Hollander Rounds: Clinical Problem Solving with Rabih Geha and Reza Manesh • youtu.be/lOX3B_PukT4October 1: Prostate Cancer in 2024: Recent Updates and Treatment Advances • youtube.com/watch?v=47RJ7THtCVESeptember 24: Optimizing the Clinical Encounter: The Science of Listening • youtu.be/LsgWNE_f24w?feature=shared
Hospital Medicine: The Year in Review UCSF Department of Medicine 2024-10-31 | The field of hospital medicine encompasses the care of patients with acute illness, across all medical specialties. Bradley Monash, MD, and Bradley Sharpe, MD, both award-winning clinician-educators and program leaders in the Division of Hospital Medicine at UCSF Health, will describe recent evidence-based changes in treating hospitalized patients and discuss the challenges in keeping up-to-date on the current literature. Speaker(s)Bradley Monash, MD, Professor of Medicine and Pediatrics, Vice Chief of Clinical Affairs, Division of Hospital Medicine at UCSF Health Bradley Sharpe, MD, Professor of Medicine, Division of Hospital Medicine at UCSF Health Program Bob Wachter: Introduction 1:44-52:57 — Bradley Monash, MD & Bradley Sharpe, MD52:57-1:00:47 — ReflectionsSee previous Medical Grand Rounds: October 22: Hollander Rounds: Clinical Problem Solving with Rabih Geha and Reza Manesh • youtu.be/lOX3B_PukT4October 1: Prostate Cancer in 2024: Recent Updates and Treatment Advances • youtube.com/watch?v=47RJ7THtCVESeptember 24: Optimizing the Clinical Encounter: The Science of Listening • youtu.be/LsgWNE_f24w?feature=sharedSeptember 10: Generative AI in the DOM: Cutting-Edge Applications and Innovations • youtu.be/ZxrZ9Y1CsE4?feature=shared
Hollander Rounds: Clinical Problem Solving with Rabih Geha and Reza Manesh UCSF Department of Medicine 2024-10-24 | In our upcoming Hollander Rounds, we're presenting another Clinical Problem Solving (CPS) case that offers listeners a real-time opportunity to observe how master clinicians reason through challenging cases. While getting the diagnosis “right” is impressive, the true learning comes from witnessing how experts navigate the zigs and zags of a diagnostic journey in a case that unfurls in real-time (as it does in life, of course). Speaker(s)Rabih Geha, MD, Associate Professor of Medicine, Division of Emergency Services & Director of Education of the ED at the SFVAHCS Reza Manesh, MD, Associate Professor of Medicine, UCLA School of Medicine & Director of Didactic Teaching at the VA Greater Los Angeles Program Bob Wachter: Introduction 3:20-55:50 — Rabih Geha, MD & Reza Manesh, MD55:50-58:11 — ReflectionsSee previous Medical Grand Rounds: October 1: Prostate Cancer in 2024: Recent Updates and Treatment Advances • youtube.com/watch?v=47RJ7THtCVESeptember 24: Optimizing the Clinical Encounter: The Science of Listening • youtu.be/LsgWNE_f24w?feature=sharedSeptember 10: Generative AI in the DOM: Cutting-Edge Applications and Innovations • youtu.be/ZxrZ9Y1CsE4?feature=shared
Implications of the 2024 Election on Health Policy UCSF Department of Medicine 2024-10-11 | The upcoming 2024 election has profound implications for health policy, and we can think of no better national expert to discuss this with than Ashish Jha, currently Dean of the Brown University School of Public Health. Ashish served as White House COVID-19 Coordinator in 2022-2023, and was director of Harvard’s Global Health Institute from 2014-2020. Ashish, who was a UCSF resident and chief resident in the late 1990s, is arguably the nation’s leading expert in evidence-based healthcare policy. In literally hundreds of national media appearances, he was a trusted source of information during the COVID era. We’ll discuss the health policy proposal of the current presidential candidates, reflect on the key issues facing the healthcare system, and try to predict the future of U.S. health care policy. Speaker Ashish K. Jha, MD, MPH, Dean, School of Public Health, Brown University Program Bob Wachter: Introduction 2:29-59:42 — Ashish K. Jha, MD, MPHSee previous Medical Grand Rounds: October 1: Prostate Cancer in 2024: Recent Updates and Treatment Advances • youtube.com/watch?v=47RJ7THtCVESeptember 24: Optimizing the Clinical Encounter: The Science of Listening • youtu.be/LsgWNE_f24w?feature=sharedSeptember 10: Generative AI in the DOM: Cutting-Edge Applications and Innovations • youtu.be/ZxrZ9Y1CsE4?feature=shared
Prostate Cancer in 2024: Recent Updates and Treatment Advances UCSF Department of Medicine 2024-10-04 | Several recent scientific advances have revolutionized treatment for prostate cancer, the most common non-skin cancer in American men. Unfortunately, many patients develop treatment resistance through androgen receptor mutations and other forms of molecular trickery. In this Medical Grand Rounds, we will explore recent therapeutic advances, including imaging techniques and novel immunotherapies, dive into resistance mechanisms, and discuss promising new options for managing resistant cases and enhancing survival rates. Speaker Rahul Aggarwal, MD, Thomas Perkins Distinguished Professor of Cancer Research, Division of Hematology and Oncology at UCSF Health & Program Director, Genitourinary Medical Oncology Program Program Bob Wachter: Introduction 1:17-48:15 — Rahul Aggarwal, MD48:15-59:31 — Panel Q&ASee previous Medical Grand Rounds: September 24: Optimizing the Clinical Encounter: The Science of Listening • youtu.be/LsgWNE_f24w?feature=sharedSeptember 10: Generative AI in the DOM: Cutting-Edge Applications and Innovations • youtube.com/watch?v=ZxrZ9Y1CsE4&t=0s
Optimizing the Clinical Encounter: The Science of Listening UCSF Department of Medicine 2024-09-27 | Despite the rapid technological advancements in healthcare, there is one free intervention that has been proven to transform care and optimize health outcomes: effective listening. In addition to helping patients, effective listening could serve as a prescription for physicians in this time of burnout. In this Grand Rounds, Dean Schillinger, UCSF faculty member and author of an acclaimed new book, will offer insights into the different forms of listening and explore the connection between attention and patient well-being and clinical outcomes.Speaker:Dean-David Schillinger, MD, is the director of the UCSF Health Communications Research program and is a UCSF primary care physician, scientist, author, public health leader, and international expert in health communication.Program Lekshmi Santhosh: Introduction 1:30-55:00 — Dean-David Schillinger55:00-1:04:00 — Panel Q&ASee previous Medical Grand Rounds: September 10: Generative AI in the DOM: Cutting-Edge Applications and Innovationsyoutube.com/watch?v=ZxrZ9Y1CsE4
Generative AI in the DOM: Cutting-Edge Applications and Innovations UCSF Department of Medicine 2024-09-13 | Artificial intelligence promises to transform every industry (and everything else!), but how is it actually changing how we teach, do research, and deliver clinical care at UCSF today? In this Medical Grand Rounds, the first of the 2024-2025 academic year, we provide an interactive overview of the various AI technologies available to faculty, staff, and trainees, and illustrate their current applications within the DOM. We will see how our people are beginning to accelerate data analysis, automate routine tasks, create new content, and deliver interactive simulations.SpeakersAugusto Garcia-Agundez, PhD, postdoctoral researcher in the Division of Rheumatology based at ZSFG.Jin Ge, MD, MBA, assistant professor of medicine in the Division of Gastroenterology at UCSF Health and the Division of Clinical Informatics and Digital Transformation. Elaine Khoong, MD, MS, assistant professor in the Division of General Internal Medicine at ZSFG and the Division of Clinical Informatics and Digital Transformation.Logan Pierce, MD, assistant professor of medicine in the Division of Hospital Medicine at UCSF Health and the Division of Clinical Informatics and Digital Transformation.Program Bob Wachter: Introduction 4:45-14:30 — Jin Ge, MD, MBA14:30-26:15 — Elaine Khoong, MD, MS26:15-35:00 — Logan Pierce, MD35:00-41:30 — Augusto Garcia-Agundez, PhD41:30-1:04:30 — Panel Q&ASee previous Medical Grand Rounds: June 6: Exploring Barriers to Giving and Receiving Feedback in the DOMyoutu.be/Hb95VWhys5YMay 30: Updates in Valvular Heart Disease Assessment and Management 2024:A Multidisciplinary Approachyoutu.be/mbmi4GG0GIsMay 23: Finding Your North Star in Medical Education: Lessons from my Life as a Residency Director, Med Ed Dean, and CEO of the Macy Foundationyoutu.be/7XV61wn8KpIMay 16: Bedside to Bench: Epithelial Cell Reprogramming in Pulmonary Fibrosisyoutu.be/2jwY_MzcTkk
Update on respiratory infections for the summer: COVID-19, influenza, mpox and more UCSF Department of Medicine 2024-06-15 | Session moderated by Bob WachterIn our final Grand Rounds of the academic year, we'll delve into the current epidemiology of COVID-19 and H5N1 influenza A in the United States, among other viruses. We’ll review the latest data and trends, this summer's "forecast," and how individuals and institutions can better prepare for prevention and mitigation. The session will begin with an epidemiology update with George Rutherford and then move to a Q&A with Alison Bond, Peter Chin-Hong, and Deborah Yokoe on H5N1, COVID, measles, and beyond.SpeakersAllison Bond, MD, MA, is assistant professor, Division of Hospital Medicine and Division of Infectious Diseases at UCSF Health.Peter Chin-Hong, MD, is professor of medicine, Division of Infectious Diseases at UCSF Health and associate dean for regional campuses, UCSF School of Medicine.George Rutherford, MD, is professor of epidemiology, preventive medicine, pediatrics and history and director, Center for Global Strategic Information and Public Health Practice, Institute for Global Health Sciences.Deborah Yokoe, MD, MPH, is professor of clinical medicine, Division of Infectious Diseases and medical director for Hospital Epidemiology and Infection Prevention for the adult services at UCSF Health and past president of the Society for Healthcare Epidemiology of America (SHEA).Program Bob Wachter: Introduction 4:45-16:15 — George Rutherford, MD16:15-1:00:50 — Panel Q&ASee previous Medical Grand Rounds: June 6: Exploring Barriers to Giving and Receiving Feedback in the DOMyoutu.be/Hb95VWhys5YMay 30: Updates in Valvular Heart Disease Assessment and Management 2024:A Multidisciplinary Approachyoutu.be/mbmi4GG0GIsMay 23: Finding Your North Star in Medical Education: Lessons from my Life as a Residency Director, Med Ed Dean, and CEO of the Macy Foundationyoutu.be/7XV61wn8KpIMay 16: Bedside to Bench: Epithelial Cell Reprogramming in Pulmonary Fibrosisyoutu.be/2jwY_MzcTkk
Exploring Barriers to Giving and Receiving Feedback in the DOM UCSF Department of Medicine 2024-06-11 | Effective feedback is a cornerstone of medical education, but the culture around feedback seems to have changed in recent years. Clinicians and educators know that time constraints, workload pressures, and hierarchical structures can all impede constructive feedback and productive exchanges with trainees. In this Grand Rounds, medical education experts Brian Schwartz, Bridget O’Brien, Griffin Plattner, and Jackeline Vajta will explore the barriers to productive feedback within the DOM, followed by a panel discussion offering trainee and faculty perspectives on improving the culture of feedback at UCSF and beyond.SpeakersBrian Schwartz, MD, professor of medicine, is an infectious disease specialist, with a focus on infections in immunocompromised patients. He serves as the Associate Chair for Education for the Department of Medicine. He previously served as the Program Director of UCSF’s Infectious Diseases Fellowship and Course Director for the Pathogens and Host Defense block in the School of Medicine. Brian was the inaugural Chair of the Medical Education Community of Practice for the Infectious Diseases Society of America and the Chair of the Microbiology/Immunology Item Writing Committee for the National Board of Medical Examiners. Bridget O’Brien, PhD, is a professor of medicine and an education scientist in the Office of Medical Education's Center for Faculty Educators. As co-director of the Teaching Scholars Program and the UCSF-University of Utrecht Health Professions Education doctoral program, she teaches and mentors faculty and learners interested in education research and scholarship. She also directs the Advanced Fellowship in Health Professions Education Evaluation and Research based at the SFVA. In 2015, she was selected as one of five national Macy Faculty Scholars supported by the Josiah Macy Jr. Foundation and in 2021, Bridget was selected as a KIPRIME Fellow at the Karolinska Instituet. Griffin Plattner, MD, received his bachelor’s degrees in business management and chemical engineering from the University of Florida. He then earned his medical degree at Washington University in St. Louis before completing a primary care medicine residency at Massachusetts General Hospital. Griffin is now a National Clinical Scholars Fellow at UCSF with research interests in medical education, community-based healthcare delivery, and health equity. Jackeline Vajta, MD, is a fellow in Academic Hospital Medicine. She completed her medicine residency at Saint Mary’s Hospital-Yale School of Medicine. She is passionate about research in medical education and cardiovascular medicine. This year, she received The Academy of Medical Educators Cooke Award for the Scholarship of Teaching and Learning.Program Bob Wachter: Introduction 2:20-8:30 — Brian Schwartz, MD, a professor of medicine and an infectious disease specialist8:30-17:50 — Bridget O’Brien, PhD, a professor of medicine and an education scientist17:50-20:20 — Griffin Plattner, MD, a National Clinical Scholars fellow at UCSF20:20-24:45 — Jackeline Vajta, MD, a fellow in Academic Hospital Medicine25:20-1:05:00 — PanelSee previous Medical Grand Rounds: May 30: Updates in Valvular Heart Disease Assessment and Management 2024:A Multidisciplinary Approachyoutu.be/mbmi4GG0GIsMay 23: Finding Your North Star in Medical Education: Lessons from my Life as a Residency Director, Med Ed Dean, and CEO of the Macy Foundationyoutu.be/7XV61wn8KpIMay 16: Bedside to Bench: Epithelial Cell Reprogramming in Pulmonary Fibrosisyoutu.be/2jwY_MzcTkk
Updates in Valvular Heart Disease Assessment and Management 2024:A Multidisciplinary Approach UCSF Department of Medicine 2024-06-01 | Treatment of complex valvular heart disease has changed dramatically over the last decade, illustrated by both advances in open-heart surgery and the advent of minimally invasive approaches. In this Grand Rounds, we will hear from a cardiac surgeon, interventional cardiologist, and non-invasive cardiologist about their multidisciplinary approach to complex valvular disease. We’ll also learn about current guidelines for the management of mitral, aortic, and tricuspid valvular disease.SpeakersTobias Deuse, MD, a cardiothoracic surgeon, is director of minimally invasive cardiac surgery at UCSF. He is well known for developing minimally invasive techniques for mitral valve repair, as well as innovative approaches to heart failure surgery (most notably minimally invasive techniques for implanting ventricular assist systems and mitral valve repair utilizing fully robot-assisted endoscopic surgery). Deuse’s honors include election to the board of directors of the International Society for Heart and Lung Transplantation. Sammy Elmariah, MD, MPH, is an interventional cardiologist specializing in caring for patients with valve disease, coronary artery disease, and adult congenital heart disease. He is a leader in transcatheter heart valve procedures, including transcatheter aortic valve replacement (TAVR), edge-to-edge mitral valve repair (MitraClip and TEER), mitral valve replacement (TMVR), and new approaches for tricuspid valve disease. His research focuses on the prediction and optimization of clinical outcomes of patients with aortic stenosis and after TAVR. Kirsten Tolstrup, MD, is a non-invasive cardiologist with a special interest in echocardiography, valvular disease, and structural heart disease. She works closely with the interventional team on transcatheter-based procedures such as TAVR and MitraClip and on optimizing our multidisciplinary team approach to cardiovascular care at UCSF.Program Bob Wachter: Introduction 2:30-21:40 — Kirsten Tolstrup, MD, a non-invasive cardiologist21:40-37:20 — Sammy Elmariah, MD, MPH, an interventional cardiologist37:20-45:20 — Tobias Deuse, MD, a cardiothoracic surgeon45:20-1:03:00 — Q&ASee previous Medical Grand Rounds: May 9: Bedside to Bench: Epithelial Cell Reprogramming in Pulmonary Fibrosisyoutu.be/2jwY_MzcTkkMay 2: An Immunotherapy Renaissance in Hepatobiliary Cancersyoutu.be/e2O-ZHWSPHMApril 25: Diagnosis: Teaching, Measuring, Innovatingyoutu.be/Kd4YAK_XgUsApril 18: The Devastating Effect of Covid-19 on Patients with End-Stage Kidney Diseaseyoutu.be/rfiF-3z0TBo
Finding Your North Star in Medical Education UCSF Department of Medicine 2024-05-28 | Lessons from my Life as a Residency Director, Med Ed Dean, and CEO of the Macy FoundationWhile many parts of medical education have changed rapidly over the past few years, other aspects seem remarkably static. This year's Holly Smith lecturer, Dr. Holly J. Humphrey, is an international leader in medical education who is currently President and CEO of the Josiah Macy Jr. Foundation. Her work has influenced the national dialogue in medical education in areas such as diversity and inclusion, mentoring, and professional identity formation. Dr. Humphrey will offer her views on the current status of medical education and how it needs to evolve to meet trainees’ and society’s needs.The annual Holly Smith Visiting Professorship is the Department of Medicine’s most prestigious yearly lectureship. It is named for Lloyd Hollingsworth “Holly” Smith Jr., MD, a visionary physician-scientist whose uncompromising quest for excellence helped transform UC San Francisco into the world-renowned institution it is today. Smith, who passed away in 2018, served 35 years as chair of the Department of Medicine and associate dean at the UCSF School of Medicine.SpeakerHolly J. Humphrey, MD, MACP, is president of the Josiah Macy Jr. Foundation, the only U.S. foundation whose focus is health professions education. Prior to her current role, she served as Dean for Medical Education and as Internal Medicine Residency Program Director at The University of Chicago. She was selected as a favorite faculty teacher by graduating University of Chicago medical students more than 25 times. A pulmonary and critical care physician by training, she is an elected member of the National Academy of Medicine, a Master of the American College of Physicians, a Fellow of the Royal College of Physicians (London), and recipient of numerous other national and international awards.Program Bob Wachter: Introduction 4:30-48:40 — Holly J. Humphrey, MD, MACP48:40-59:40 — Q&ASee previous Medical Grand Rounds: May 9: Bedside to Bench: Epithelial Cell Reprogramming in Pulmonary Fibrosisyoutube.com/watch?v=2jwY_MzcTkkMay 2: An Immunotherapy Renaissance in Hepatobiliary Cancersyoutu.be/e2O-ZHWSPHMApril 25: Diagnosis: Teaching, Measuring, Innovatingyoutu.be/Kd4YAK_XgUs
Bedside to Bench: Epithelial Cell Reprogramming in Pulmonary Fibrosis UCSF Department of Medicine 2024-05-13 | The field of interstitial lung diseases, with its alphabet soup of entities (IPF, NSIP, HP, and more), has seen significant progress in the past few years. Much of this progress has been catalyzed by a new understanding of the pathophysiology of ILD, including the role of cellular aging in pulmonary fibrosis. In this Grand Rounds, Tien Peng and Paul Wolters provide clinical updates in the management of patients with pulmonary fibrosis and describe emerging research on the role that epithelial cells and telomere dysfunction play in these often debilitating conditions.SpeakersTien Peng, MD, is a pulmonary physician-scientist who runs the innovative Peng Lab, which uses complex murine genetic models and human specimens to investigate how fibroblasts maintain organ homeostasis, initiate disease, and drive tissue aging.Paul Wolters, MD, is a pulmonary physician-scientist who specializes in the diagnosis and care of patients with interstitial lung disease. His research investigates the molecular pathogenesis of fibrotic lung disease to help develop novel therapies.Program Bob Wachter: Introduction 2:30-24:10 — Paul Wolters, MD, pulmonary physician-scientist24:10-42:00 — Tien Peng, MD, pulmonary physician-scientist42:00-57:50 — Q&ASee previous Medical Grand Rounds: May 2: An Immunotherapy Renaissance in Hepatobiliary Cancersyoutu.be/e2O-ZHWSPHMApril 25: Diagnosis: Teaching, Measuring, Innovatingyoutu.be/Kd4YAK_XgUsApril 18: The Devastating Effect of Covid-19 on Patients with End-Stage Kidney Diseaseyoutu.be/rfiF-3z0TBoApril 11: Immune Effector Cell Therapy in Hematologic Malignancies: Lessons Learnedyoutu.be/zlb9jKgn99U
An Immunotherapy Renaissance in Hepatobiliary Cancers UCSF Department of Medicine 2024-05-07 | Immunotherapy has revolutionized the way we treat many malignancies, including hepatobiliary cancers. In this Grand Rounds, UCSF oncologists Katie Kelley, MD and Bridget Keenan, MD, PhD, will discuss the newest developments in using immunotherapy to treat these cancers as well as their unique bench-to-bedside translational approach.SpeakersKatie Kelley, MD, is a gastrointestinal oncologist who specializes in cancers arising from the liver, including hepatocellular carcinoma, bile duct cancer (cholangiocarcinoma), and gallbladder carcinoma. Her research interests are in developing clinical trials of new treatments (including immunotherapy approaches) and combination therapies for these cancers, as well as translational research to identify molecular and genetic biomarkers of response.Bridget Keenan, MD, PhD, is a physician-scientist who works in translational cancer research and medical oncology at the Cancer Immunotherapy Clinic. In the clinic, she cares for patients with solid organ cancers who are being treated on early phase immunotherapy trials. Her research focuses on the mechanisms of response and resistance to immunotherapy, particularly in gastrointestinal cancers.Program Bob Wachter: Introduction 2:40-10:30; 14:15-25:45; 39:00-41:25 — Katie Kelley, MD, gastrointestinal oncologist10:30-14:15; 25:45-39:00— Bridget Keenan, MD, PhD, physician-scientist48:00-1:00:50 — Q&ASee previous Medical Grand Rounds: April 25: Diagnosis: Teaching, Measuring, Innovatingyoutu.be/Kd4YAK_XgUsApril 18: The Devastating Effect of Covid-19 on Patients with End-Stage Kidney Diseaseyoutu.be/rfiF-3z0TBoApril 11: Immune Effector Cell Therapy in Hematologic Malignancies: Lessons Learnedyoutu.be/zlb9jKgn99UMarch 21: From Pipettes to Populations: Building an Integrated Program for ID Research and Educationyoutu.be/ErYI-6fb-14
Diagnosis: Teaching, Measuring, Innovating UCSF Department of Medicine 2024-04-26 | The critical thinking required to diagnose a patient’s condition is fundamental to our work as internists. Yet if done poorly, diagnostic errors and inequities can deeply harm patients – in fact, studies have shown that several hundred thousand patients die or suffer major harm from diagnostic mistakes each year. In this Grand Rounds, we’ll have three expert faculty explore fundamental issues in diagnosis, each seen through their specialized lenses of research, informatics, and education. We will explore the measurement of diagnostic errors, the ability to harness AI to enhance diagnostic reasoning, and the future of diagnostic excellence. This year, our department became the home of a national Coordinating Center for Diagnostic Excellence (CoDEx), funded by a $15 million grant from the Gordon and Betty Moore Foundation.SpeakersJulia Adler-Milstein, PhD, is a professor of Medicine, chief of the Division of Clinical Informatics & Digital Transformation (DoC-IT), and director of the Center for Clinical Informatics & Improvement Research (CLIIR). She is also leading CoDEx. Julia is a leading researcher in health IT policy, with a specific focus on electronic health records, interoperability, and the use of EHR data to study clinician behavior.Andrew Auerbach, MD, MPH, is a professor of Medicine in the Division of Hospital Medicine. He is a widely recognized leader in Hospital Medicine, having authored seminal research describing effects of hospital medicine systems on patient outcomes, costs, and care quality. He leads a 13-hospital research collaborative (“HOMERuN”) focused on new discoveries in healthcare delivery models in acute care settings.Gurpreet Dhaliwal, MD, is a clinician-educator and professor of Medicine. He is also site director of the internal medicine clerkship at the San Francisco VA Medical Center, where he teaches medical students and residents in the ED, urgent care clinic, inpatient wards, and outpatient clinic. He is a Master Clinician and an award-winning educator with a focus on the cognitive processes underlying diagnostic reasoning and clinical problem-solving and the study of diagnostic expertise. Program Bob Wachter: Introduction 4:30-20:10 — Gurpreet Dhaliwal, MD, clinician-educator and professor of Medicine20:10-32:10 — Andrew Auerbach, MD, MPH, professor of Medicine in the Division of Hospital Medicine 32:10-45:15 — Julia Adler-Milstein, PhD, professor of Medicine, chief of the Division of Clinical Informatics & Digital Transformation (DoC-IT), and director of the Center for Clinical Informatics & Improvement Research (CLIIR)45:15-1:04:50 — Q&ASee previous Medical Grand Rounds: April 18: The Devastating Effect of Covid-19 on Patients with End-Stage Kidney Diseaseyoutu.be/rfiF-3z0TBoApril 11: Immune Effector Cell Therapy in Hematologic Malignancies: Lessons Learnedyoutu.be/zlb9jKgn99UMarch 21: From Pipettes to Populations: Building an Integrated Program for ID Research and Educationyoutu.be/ErYI-6fb-14March 14: 31st Annual Alice Hamilton Lecture: Dust in the Lungs, an Ancient Disease Still with Usyoutu.be/HoIwH6Qk-Ks?si=WRZQA4oLh1sIFh6q
The Devastating Effect of Covid-19 on Patients with End-Stage Kidney Disease UCSF Department of Medicine 2024-04-19 | Covid-19 has had immense impacts on our healthcare system, including on the care of our most vulnerable patients such as those with end-stage kidney disease. For our annual Kardos Medical Grand Rounds, Dr. Kirsten Johansen, professor of Medicine at the University of Minnesota Medical School and chief of Nephrology at Hennepin Healthcare, will provide insights into the impact of Covid-19 on individuals battling end-stage kidney disease.This lecture is held in memory of Dr. Gary Kardos, who was an esteemed clinician-educator nephrologist at UCSF for several decades.SpeakerKirsten Johansen, MD, completed her Nephrology fellowship at UCSF and was on our faculty for many years before being recruited to the University of Minnesota. She is currently a professor of Medicine at Minnesota, director of the Nephrology Division at Hennepin Healthcare, president of the Hennepin Healthcare Research Institute, and director of the United States Renal Data System. Her research centers on the epidemiology of kidney disease and how to improve the quality of life among patients with kidney disease.Note: Closed captions will be available within 48-72 hours after posting.Program Bob Wachter: Introduction 2:39-42:42 — Kirsten Johansen, MD, professor of Medicine at Minnesota, director of the Nephrology Division at Hennepin Healthcare, president of the Hennepin Healthcare Research Institute, and director of the United States Renal Data System42:50-55:27 — Q&ASee previous Medical Grand Rounds: April 11: Immune Effector Cell Therapy in Hematologic Malignancies: Lessons Learnedyoutu.be/zlb9jKgn99UMarch 21: From Pipettes to Populations: Building an Integrated Program for ID Research and Educationyoutu.be/ErYI-6fb-14March 14: 31st Annual Alice Hamilton Lecture: Dust in the Lungs, an Ancient Disease Still with Usyoutu.be/HoIwH6Qk-Ks?si=WRZQA4oLh1sIFh6qMarch 7: Hollander Rounds: Clinical Problem Solving with Monica Fungyoutu.be/x63ol_4oJ1oSee all UCSF grand rounds, which have been viewed over 3M times, at youtube.com/playlist?list=PLp2l8GCZXFqSgUfwaResQ7rGwKbGIUi_m.
Immune Effector Cell Therapy in Hematologic Malignancies: Lessons Learned UCSF Department of Medicine 2024-04-16 | The fields of bone marrow transplantation and malignant hematology have been transformed in recent years. In this Grand Rounds, we will explore novel therapies, such as the use of immune effector cells in hematological malignancies. We will discuss the rationale behind these treatments and practical clinical pearls in the management of patients with hematologic malignancies.Speakers:Babis Andreadis, MD, MS, is a professor in the Division of Hematology and Oncology at UCSF Health and director of the Baszucki Lymphoma Therapeutic Initiative for the UCSF Helen Diller Family Comprehensive Cancer Center. His research interests include drug toxicity and genetic and patient factors behind differential responses to therapy.Ajai Chari, MD, is also a professor in the Division of Hematology and Oncology at UCSF Health. He is also the director of the Multiple Myeloma Program. His research interests include the development of novel chemotherapy regimens, including Phase 1 and 2 national and international trials.Note: Closed captions will be available within 48-72 hours after posting.Program Bob Wachter: Introduction 2:25-24:56 — Babis Andreadis, MD, MS, professor in the Division of Hematology and Oncology at UCSF Health24:59-39:05 — Ajai Chari, MD, professor in the Division of Hematology and Oncology at UCSF Health39:09-59:46 — Q&ASee previous Medical Grand Rounds: March 21: From Pipettes to Populations: Building an Integrated Program for ID Research and Educationyoutu.be/ErYI-6fb-14March 14: 31st Annual Alice Hamilton Lecture: Dust in the Lungs, an Ancient Disease Still with Usyoutu.be/HoIwH6Qk-Ks?si=WRZQA4oLh1sIFh6qMarch 7: Hollander Rounds: Clinical Problem Solving with Monica Fungyoutu.be/x63ol_4oJ1oFebruary 29: Lifestyle and Atrial Fibrillation: Adventures in Clinical Researchyoutu.be/C7JnJr4hj-YSee all UCSF grand rounds, which have been viewed over 3M times, at youtube.com/playlist?list=PLp2l8GCZXFqSgUfwaResQ7rGwKbGIUi_m.
